Search for: "v. Bird et al"
Results 121 - 140
of 163
Sorted by Relevance
|
Sort by Date
5 Apr 2022, 10:45 am
Victoria Mastronardi, et al., Northern District of Georgia, Atlanta Division, Case No. 1:20-cv-4583-MLB. [read post]
9 Dec 2019, 7:23 am
Aeroquip Credit Union et al, 936 F.3d 489 (6th Cir. [read post]
2 Apr 2018, 7:12 am
Barbara Callado, et al. [read post]
16 Jul 2013, 8:55 am
Board of Trustees and City of Hayward v. [read post]
27 May 2021, 8:27 am
Officer Jeff Dewar, Et. [read post]
1 Jun 2010, 11:05 pm
Is it a bird? [read post]
13 Jun 2011, 4:14 am
INVENTIO AG et al. [read post]
3 Oct 2011, 4:29 am
Motion Picture Theatre Associations of Canada, et al. [read post]
21 Mar 2023, 1:09 pm
City of Los Angeles (Rony Shram, et al, Real Parties in Interest) (2023) ___ Cal.App.5th ___. [read post]
17 Aug 2011, 2:00 am
Shareholders Litigation was sent in by Alston & Bird Partner and Practice Center Contributor, Kevin Miller. [read post]
30 Jun 2012, 9:42 am
But the case that every first year law student encounters within days of starting their Torts class (unless taught by a pamphleteer) is Bird v. [read post]
3 Nov 2009, 4:55 pm
District Court for the Northern District of California on June 15, 2009 (CBD, et al. v. [read post]
24 Oct 2010, 5:45 pm
Goossens H, Giesendorf AJ, Vandamme P, et al. (1995). [read post]
16 Aug 2010, 4:36 am
Goossens H, Giesendorf AJ, Vandamme P, et al. (1995). [read post]
25 Apr 2019, 11:23 am
Goossens H, Giesendorf AJ, Vandamme P, et al. (1995). [read post]
13 Jul 2011, 11:49 am
[ET AL.] [read post]
14 Jul 2011, 9:23 am
[ET AL.] [read post]
12 Jul 2012, 7:30 am
Case No.: 6:07-cv-839-Orl-35-KRS SECRETARY, DEPARTMENT OF CORRECTIONS, et. al., Respondents. [read post]
8 Aug 2017, 4:58 pm
Friedman et. al., Advising Family Businesses in the Twenty-First Century: An Introduction to Stage 4 Planning Strategies, 65 BUFF. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
